Zomedica Corp. (ZOMDF) stock
ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.08−0.00 (-0.55%)
Close on Oct 19, 2026Market cap $77.40MP/E –Yield –
Zomedica price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Zomedica's price to sales ratio was 2.1× on Oct 19, 2026, against 2.6× a year earlier. Over the last 5 years it ranged from 1.4× to 85.4×, with a median of 5.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 2.1× | −1.3 |
| 2025 | Dec 31, 2025 | 3.4× | −1.0 |
| 2024 | Dec 31, 2024 | 4.4× | −3.8 |
| 2023 | Dec 29, 2023 | 8.2× | −1.3 |
| 2022 | Dec 30, 2022 | 9.5× | – |
See a number that looks wrong?